Obesity Factor Ups Bone-marrow Cancer Risk

Published Online: Tuesday, November 1, 2005

Researchers have uncovered additional evidence to support how obesity may increase a woman's risk of developing multiple myeloma. The results of earlier studies looking into the possible link between excess weight and the disease were inconsistent, reported researchers in Epidemiology (September 2005).

The current study looked at several characteristics to examine the relationship between the bone-marrow cancer and obesity. The characteristics included body mass index (BMI), weight alone, waist-to-hip ratio, and individual waist and hip measurements.

The findings were based on data for 37,083 postmenopausal women followed for 16 years. Women with a BMI of ≥30 were 1.5 times more likely to be diagnosed with multiple myeloma. The participants with the greatest weight, waist circumference, or hip circumference had a doubled risk. No relationship was found between waist-to-hip ratio and multiple myeloma risk.

Latest Articles
A pharmacy robber not only left his fingerprints behind at a pharmacy—he also dropped his wallet containing his identification as he made his escape.
Janssen Research and Development LLC has submitted a new drug application to the FDA for canagliflozin and metformin hydrochloride extended release (Invokamet XR).
Treating chronic pulmonary obstructive disease with both inhaled corticosteroids and long-acting bronchodilators remains controversial, but new evidence suggests that this controller combination could reduce mortality risk.
Beverly Schaefer, RPh, of Katterman's Sand Point Pharmacy in Seattle, Washington, shares some fun tips on how to encourage patients who travel to come to your pharmacy for supplies.
Latest Issues